One pill, once a day
If other treatments like 5-ASAs† or steroids aren’t working well enough* for you, ask your doctor about oral VELSIPITY.
†5-ASAs are 5-aminosalicylic acid derivatives.
*In VELSIPITY studies, people with moderately to severely active ulcerative colitis had an inadequate response, loss of response, or intolerance to one or more of the following treatment options: oral aminosalicylates, corticosteroids, thiopurines, Janus kinase (JAK) inhibitors, or biologics prior to enrollment.
Learn more about VELSIPITY
VELSIPITY.
Help Calm the Chaos of UC.
[VELSIPITY logo] Help Calm the Chaos of UC
1-800-350-3080 | Visit VELSIPITY.com for cost info [Pfizer logo]
PP-V1A-USA-0732 ©2024 Pfizer, Inc.
All rights reserved. December 2024.
More people on VELSIPITY achieved clinical remission* in just 3 months versus those taking the placebo.
VELSIPITY is the newest medication of its class for moderate to severe UC in adults.
The safety of VELSIPITY was studied in a clinical program with 577 participants across 3 placebo-controlled studies.
Explore the details of VELSIPITY.
Select one from the list to learn more.
VELSIPITY could be a chance to help manage moderate to severe UC.
Want to learn more about VELSIPITY?